Tevogen Bio Holdings Inc. (TVGN)
- Previous Close
0.8500 - Open
1.1990 - Bid 0.8100 x 100
- Ask 1.0100 x 300
- Day's Range
0.9300 - 1.2000 - 52 Week Range
0.8030 - 21.0900 - Volume
10,746,254 - Avg. Volume
540,430 - Market Cap (intraday)
164.614M - Beta (5Y Monthly) 0.05
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.
tevogen.comRecent News: TVGN
Performance Overview: TVGN
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TVGN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TVGN
Valuation Measures
Market Cap
164.61M
Enterprise Value
251.99M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-4.05
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-62.57M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
2.61M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--